Protein profiling and transcript expression levels of heat shock proteins in 17β-estradiol-treated human MCF-7 breast cancer cells

Cell Biology International

Volumn 30, Issue 12, 2006, Pages 983-991

  Lee, Su Ui ^a   Kim, Bum Tae ^a   Min, Yong Ki ^a   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

17 Estradiol; Breast cancer; Heat shock proteins; Proteomics; Real time PCR

Indexed keywords

AMINOACYLASE; ESTRADIOL; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 56; HEAT SHOCK PROTEIN 90ALPHA; PROTEIN; PROTEIN DISULFIDE ISOMERASE REGULATED PROTEIN; STATHMIN 1; UNCLASSIFIED DRUG; XTP3 TRANSACTIVATED PROTEIN A;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SERUM; UPREGULATION;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEOMICS; SERUM;

EID: 33751010514     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.07.005     Document Type: Article

References (36)

1. Balabanov S., Zimmermann U., Protzel C., Scharf C., Klebingat K.J., and Walther R. Tumor-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. Eur J Biochem 268 (2001) 5977-5980
2. Beliakoff J., and Whitesell L. Hsp90: an emerging target for breast cancer therapy. Anti-cancer Drugs 15 (2004) 651-662
3. Berthois Y., Katzenellenbogen J.A., and Katzenellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83 (1986) 2496-2500
4. Bowman C.J., Kroll K.J., Gross T.G., and Denslow N.D. Estradiol-induced gene expression in largemouth bass (Micropterus salmoides). Mol Cell Endocrinol 196 (2002) 67-77
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
6. Cho H., Aronica S.M., and Katzenellenbogen B.S. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3′,5′-monophosphate, estradiol, insulin-like growth factor-I and serum factors. Endocrinology 134 (1994) 658-664
7. Clemons M., and Goss P. Estrogen and the risk of breast cancer. N Engl J Med 344 (2001) 276-285
8. Cook R.M., Franklin W.A., Moore M.D., Johnson B.E., and Miller Y.E. Mutational inactivation of aminoacylase-I in a small cell lung cancer cell line. Genes Chromosomes Cancer 21 (1998) 320-325
9. Csermely P., Schnaider T., Soti C., Prohaszka Z., and Nardai G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 79 (1998) 129-168
10. Curmi P.A., Nogues C., Lachkar S., Carelle N., Gonthier M.P., Sobel A., et al. Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br J Cancer 82 (2000) 142-150
11. Darbre P., Yates J., Curtis S., and King R.J. Effect of estradiol on human breast cancer cells in culture. Cancer Res 43 (1983) 349-354
12. Frasor J., Danes J.M., Komm B., Chang K.C.N., Lyttle R., and Katzenellenbogen B.S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144 (2003) 4562-4574
13. Gronemeyer H., and Laudet V. Transcription factors 3: nuclear receptors. Protein Profile 2 (1995) 1173-1308
14. Hartl F.U. Molecular chaperones in cellular protein folding. Nature 381 (1996) 571-579
15. Horwitz K.B., and McGuire W.L. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem 253 (1978) 2223-2228
16. Hwang T.S., Han H.S., Choi H.K., Lee Y.J., Kim Y.J., Han M.Y., et al. Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J Gastroenterol Hepatol 18 (2003) 690-700
17. Isaacs J.S., Xu W., and Neckers L. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3 (2003) 213-217
18. Jones W.M., Scaloni A., Bossa F., Popowicz A.M., Schneewind O., and Manning J.M. Genetic relationship between acrylpeptide hydrolase and acylase, two hydrolytic enzymes with similar binding but different catalytic specificities. Proc Natl Acad Sci USA 88 (1991) 2194-2198
19. Katzenellenbogen B.S., Bhakoo H.S., Ferguson E.R., Lan N.C., Tatee T., and Tsai T.S. Estrogen and antiestrogen action in reproductive tissues and tumors. Recent Prog Horm Res 35 (1979) 259-300
20. Kumar P., Mark P.J., Ward B.K., Minchin R.F., and Ratajczak T. Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem Biophys Res Commun 284 (2001) 219-225
21. Kuznetsov G., Chen L.B., and Nigam S.K. Multiple molecular chaperones complex with misfolded large oligomeric glycoproteins in the endoplasmic reticulum. J Biol Chem 272 (1997) 3057-3063
22. -ΔΔCT method. Methods 25 (2001) 402-408
23. Mazzarella R.A., Srinivasan M., Haugejorden S.M., and Green M. ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase. J Biol Chem 265 (1990) 1094-1101
24. McGuire W.L., Horwitz K.B., Chamness G.C., and Zava D.T. A physiological role for estrogen and progesterone in breast cancer. J Steroid Biochem 7 (1976) 875-882
25. Moroz O.V., Murzin A.G., Makarova K.S., Koonin E.V., Wilson K.S., and Galperin M.Y. Dimeric dUTPases, HisE and MazG belong to a new superfamily of all-α NTP pyrophosphohydrolases with potential "house-cleaning" functions. J Mol Biol 347 (2005) 243-255
26. Nardulli A.M., Greene G.L., O'Malley B.W., and Katzenellenbogen B.S. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 122 (1988) 935-944
27. Peattie D.A., Harding M.W., Fleming M.A., DeCenzo M.T., Lippke J.A., Livingston D.J., et al. Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc Natl Acad Sci USA 89 (1992) 10974-10978
28. Pietras R.J., and Szego C.M. Cell membrane estrogen receptors resurface. Nat Med 5 (1999) 1330
29. Rozen S., and Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics methods and protocols: methods in molecular biology (2000), Humana Press, Totowa, NJ 365-386
30. Ruedl C., Cappeletti V., Coradini D., Granata G., and Fronzo G. Influence of culture conditions on the estrogenic cell growth stimulation of human breast cancer cells. J Steroid Biochem Mol Biol 37 (1990) 195-200
31. Schultz-Norton J.R., McDonald W.H., Yates J.R., and Nardulli A.M. Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor α structure and function. Mol Endocrinol (2006 May 11) [Epub ahead of print]
32. Soto A.M., and Sonnenschein C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem 23 (1985) 87-94
33. Soufla G., Porichis F., Sourvinos G., Vassilaros S., and Spandidos D.A. Transcriptional deregulation of VEGF, FGF2, TGF-β1, 2, 3 and cognate receptors in breast tumorigenesis. Cancer Lett 235 (2006) 100-113
34. Tyran W., Jelen M., and Kolodziej J. Cobalt-activated acylase and aminoacylase 1 in human malignant tumors. Neoplasma 27 (1980) 317-320
35. Wang X.Y., Chen X., Manjili M.H., Repasky E., Henderson R., and Subjeck J.R. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer Res 63 (2003) 2553-2560
36. Ward B.K., Mark P.J., Ingram D.M., Minchin R.F., and Ratajczak T. Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res Treat 58 (1999) 267-280